Seizure and epilepsy medication recalls
25 FDA-recorded recalls of seizure and epilepsy medications, most recent Jun 2026 — newest first, straight from the FDA's own database.
Two of the largest reasons in this class are the two that matter most for epilepsy: a label error on the declared strength, and cross-contamination with another product — several primidone recalls were issued for exactly that. An anti-seizure medicine is titrated to keep a person seizure-free, so a tablet that is not the strength on the carton is a dosing error nobody can see. It is also the class where stopping abruptly is most dangerous: an interrupted anticonvulsant can trigger breakthrough seizures or status epilepticus. Check the lot, keep taking the medicine, and get a replacement.
Divalproex Sodium Delayed-Release Tablets
Class IIPresence of Foreign Tablets/Capsules
Bionpharma Inc. · Jul 29, 2026
Perampanel CIII Tablets
Class IILabeling: Label Mix-up: 10mg Perampanel CIII tablet was found in a Perampanel CIII bottle labeled Perampanel 6 mg tablets.
SUN PHARMACEUTICAL INDUSTRIES INC · Jul 1, 2026
Lacosamide Tablets
Class IIPresence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Annora Pharma Private Limited · Jul 1, 2026
Primidone Tablets
Class IIICross Contamination with Other Products: due to a potential for cross-contamination with Acemetacin API due to an issue at the API manufacturer.
Amneal Pharmaceuticals, LLC · Jun 17, 2026
Primidone Tablets
Class IIICross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Amerisource Health Services LLC · May 27, 2026
Primidone Tablets
Class IIICross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Amerisource Health Services LLC · May 27, 2026
Primidone Tablets
Class IIICross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Golden State Medical Supply Inc. · May 27, 2026
Primidone Tablets
Class IIICross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Golden State Medical Supply Inc. · May 27, 2026
Primidone Tablets USP
Class IIICross contamination with other products: API contaminated with trace amounts of Acemetacin API.
Lannett Company Inc. · May 27, 2026
Carbamazepine Extended-Release Tablets
Class IIFailed Dissolution Specifications.
Amerisource Health Services LLC · Oct 8, 2025
Lacosamide Oral Solution
Class IIDefective Container: This recall is being initiated due to a leaking unit stored horizontally.
Apotex Corp. · Jun 11, 2025
Levetiracetam 0.75% in Sodium Chloride Injection 1
Class ILABELING: LABEL MIX-UP: The infusion bag is incorrectly labeled as Levetiracetam in 0.82% Sodium Chloride Injection 500 mg/100 mL, while the aluminum overwrap packaging correctly identifies the product as Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL.
Dr. Reddy's Laboratories, Inc. · Apr 23, 2025
Lacosamide Tablets 150mg
Class IICGMP Deviations
Glenmark Pharmaceuticals Inc., USA · Apr 16, 2025
Lacosamide Tablets 200mg
Class IICGMP Deviations
Glenmark Pharmaceuticals Inc., USA · Apr 16, 2025
Lacosamide Tablets
Class IICGMP Deviations
Glenmark Pharmaceuticals Inc., USA · Apr 16, 2025
Rufinamide Tablets 200mg
Class IICGMP Deviations
Glenmark Pharmaceuticals Inc., USA · Apr 16, 2025
Lacosamide Tablets
Class IICGMP Deviations
Glenmark Pharmaceuticals Inc., USA · Apr 16, 2025
Clobazam Tablets
Class IIPresence of Foreign Tablets/Capsules
Amerisource Health Services LLC · Jan 22, 2025
Clobazam Tablets
Class IIPresence of Foreign Tablets/Capsules
Amerisource Health Services LLC · Jan 15, 2025
Clonazepam Orally Disintegrating Tablets
Class ILabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc. · Jan 15, 2025
Clonazepam Orally Disintegrating Tablet
Class ILabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc. · Jan 15, 2025
Clonazepam Orally Disintegrating Tablets
Class ILabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc. · Jan 15, 2025
Clonazepam Orally Disintegrating Tablets
Class ILabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled. The blister strips inside the product carton reflect the correct strength.
Endo USA, Inc. · Jan 15, 2025
Clonazepam Orally Disintegrating Tablets
Class ILabeling: Label Error on Declared Strength; Some cartons were incorrectly labeled as 0.125 mg instead of 0.25 mg. The blister strips inside the product carton reflect the correct strength of 0.25 mg.
Endo Pharmaceuticals, Inc. · Aug 7, 2024
Clobazam Tablets 10mg
Class IICGMP Deviations: Out of specification for residual solvents.
Micro Labs Limited · Feb 28, 2024
How to use this page
A drug appearing here does not mean your prescription is unsafe. Recalls name specific lots and manufacturers — open the recall to see the affected lot numbers, and match them against your bottle. Never stop a blood-pressure, cholesterol, diabetes, antidepressant or antibiotic medicine on your own because of a recall; confirm your lot, then ask your pharmacist for a replacement if it is affected.
Other categories: Blood pressure medication · Eye drop and ophthalmic · Cholesterol medication · Diabetes medication · Antidepressant · Antibiotic · Thyroid medication · Allergy and antihistamine · Hormonal and contraceptive · ADHD and stimulant medication · Opioid and pain medication · Asthma and inhaler · Heartburn and acid-reflux medication. See also the full recalls tracker and the recall report.
Source: the openFDA drug Enforcement (recall) database. Recalls are matched to this category by the drug names in the FDA’s product description; a small number of category recalls may be missed if the description omits the ingredient. Figures are recall events, not units, and reflect our copy of the FDA data, refreshed daily. This is public regulatory data, not medical advice.